4.7 Article

SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca2+ buffering

期刊

CELL DEATH AND DIFFERENTIATION
卷 19, 期 4, 页码 650-660

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2011.139

关键词

adenine nucleotides; ATP-Mg/Pi carriers; calcium; mitochondrial permeability transition pore; oxidative stress; cancer

资金

  1. Ministerio de Educacion y Ciencia [BFU2008-04084/BMC]
  2. Comunidad de Madrid [S-GEN-0269-2006 MITOLAB-CM]
  3. European Union [LSHM-CT-2006-518153]
  4. CIBERER (an initiative of the ISCIII)
  5. ISCIII [PI080610]
  6. Fundacion Ramon Areces
  7. Parkinson's UK [G-0905]
  8. Parkinson's UK [G-0905] Funding Source: researchfish

向作者/读者索取更多资源

Ca2+-mediated mitochondrial permeability transition (mPT) is the final common pathway of stress-induced cell death in many major pathologies, but its regulation in intact cells is poorly understood. Here we report that the mitochondrial carrier SCaMC-1/SLC25A24 mediates ATP-Mg2-/Pi(2-) and/or HADP(2-)/Pi(2-) uptake into the mitochondria after an increase in cytosolic [Ca2+]. ATP and ADP contribute to Ca2+ buffering in the mitochondrial matrix, resulting in desensitization of the mPT. Comprehensive gene expression analysis showed that SCaMC-1 overexpression is a general feature of transformed and cancer cells. Knockdown of the transporter led to vast reduction of mitochondrial Ca2+ buffering capacity and sensitized cells to mPT-mediated necrotic death triggered by oxidative stress and Ca2+ overload. These findings revealed that SCaMC-1 exerts a negative feedback control between cellular Ca2+ overload and mPT-dependent cell death, suggesting that the carrier might represent a novel target for cancer therapy. Cell Death and Differentiation (2012) 19, 650-660; doi:10.1038/cdd.2011.139; published online 21 October 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cell Biology

The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy

Celine Deneubourg, Mauricio Ramm, Luke J. Smith, Olga Baron, Kritarth Singh, Susan C. Byrne, Michael R. Duchen, Mathias Gautel, Eeva-Liisa Eskelinen, Manolis Fanto, Heinz Jungbluth

Summary: Primary dysfunction of autophagy due to Mendelian defects affecting core components of the autophagy machinery or closely related proteins has been recognized as an important cause of genetic disease. These disorders can present throughout life, with severe early-onset neurodevelopmental disorders and more common adult-onset neurodegenerative disorders. The overlap between congenital autophagy disorders and other multisystem diseases reflects the complex roles of proteins and suggests a promising area for future research.

AUTOPHAGY (2022)

Article Cell & Tissue Engineering

NOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia

Daisuke Araki, Jian Fei Fu, Heather Huntsman, Stefan Cordes, Fayaz Seifuddin, Luigi J. Alvarado, Patali S. Cheruku, Ayla Cash, Javier Traba, Yuesheng Li, Mehdi Pirooznia, Richard H. Smith, Andre Larochelle

Summary: Activation of NOTCH signaling using engineered DELTA-like ligand (DXI) under low oxygen tension culture conditions in human adult HSPCs can limit ER stress, increase the frequency of LTR-HSCs significantly, and help maintain undifferentiated phenotypes in cultured cells.

STEM CELL REPORTS (2021)

Review Biochemistry & Molecular Biology

AGC1 Deficiency: Pathology and Molecular and Cellular Mechanisms of the Disease

Beatriz Pardo, Eduardo Herrada-Soler, Jorgina Satrustegui, Laura Contreras, Araceli del Arco

Summary: AGC1/Aralar is a mitochondrial carrier involved in the transfer of redox power in neurons. Deficiency in AGC1/Aralar leads to a rare human disease and affects both neuronal and glial functions, resulting in various pathophysiological changes related to neuronal metabolism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cell Biology

Rewiring cell signalling pathways in pathogenic mtDNA mutations

Chih-Yao Chung, Gabriel E. Valdebenito, Anitta R. Chacko, Michael R. Duchen

Summary: Mutations in mitochondrial DNA have a significant impact on cellular energy homeostasis and signaling pathways, influencing disease presentation and progression.

TRENDS IN CELL BIOLOGY (2022)

Article Biology

Paradoxical neuronal hyperexcitability in a mouse model of mitochondrial pyruvate import deficiency

Andres De la Rossa, Marine H. Laporte, Simone Astori, Thomas Marissal, Sylvie Montessuit, Preethi Sheshadri, Eva Ramos-Fernandez, Pablo Mendez, Abbas Khani, Charles Quairiaux, Eric B. Taylor, Jared Rutter, Jose Manuel Nunes, Alan Carleton, Michael R. Duchen, Carmen Sandi, Jean-Claude Martinou

Summary: Neuronal excitation relies on ATP from oxidative phosphorylation, and deficient oxidative phosphorylation can lead to hyperexcitability in neurons. Inhibiting GABA activity in mice with deficient mitochondrial pyruvate carrier (MPC) led to seizures and death, but providing ketone bodies restored energy and attenuated seizures. These findings provide insights into epilepsy and other neuropathologies associated with energy deficits.
Article Biology

The PERKs of mitochondria protection during stress: insights for PERK modulation in neurodegenerative and metabolic diseases

Liliana M. Almeida, Brigida R. Pinho, Michael R. Duchen, Jorge M. A. Oliveira

Summary: PERK plays a crucial role in responding to stress in the endoplasmic reticulum and mitochondria, regulating mitochondrial dynamics, metabolism, and quality control by activating multiple protective pathways. Pharmacological activation of PERK shows protective effects in neurodegenerative and metabolic diseases, while PERK inhibition exhibits protective effects in other disease models.

BIOLOGICAL REVIEWS (2022)

Article Neurosciences

A Ca2+-Dependent Mechanism Boosting Glycolysis and OXPHOS by Activating Aralar-Malate-Aspartate Shuttle, upon Neuronal Stimulation

Irene Perez-Liebana, Ines Juaristi, Paloma Gonzalez-Sanchez, Luis Gonzalez-Moreno, Eduardo Rial, Masa Podunavac, Armen Zakarian, Jordi Molgo, Ainara Vallejo-Illarramendi, Laura Mosqueira-Martin, Adolfo Lopez de Munain, Beatriz Pardo, Jorgina Satrustegui, Araceli del Arco

Summary: Calcium acts as an important secondary messenger in regulating the bioenergetic response in neurons. In glucose-utilizing embryonic mouse cortical neurons, calcium upregulates glycolysis, pyruvate levels, and respiration through the Aralar-MAS pathway, while not affecting glucose uptake. This calcium-dependent pathway plays a key role in tuning both glycolysis and oxidative phosphorylation in response to neuronal activation.

JOURNAL OF NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Regulation of neuronal energy metabolism by calcium: Role of MCU and Aralar/malate-aspartate shuttle

Araceli del Arco, Luis Gonzalez-Moreno, Irene Perez-Liebana, Ines Juaristi, Paloma Gonzalez-Sanchez, Laura Contreras, Beatriz Pardo, Jorgina Satrustegui

Summary: Calcium plays a crucial role in regulating cellular metabolism. It controls mitochondrial respiration and cellular energy production through calcium signaling. Recent studies have shown that cytosolic calcium signals, acting on mitochondrial NADH shuttles, are important in regulating cellular metabolism in neurons using glucose as fuel. Aralar/MAS pathway, regulated by cytosolic calcium, provides substrates and fuel for respiration, while mitochondrial calcium uptake does not contribute to this process. The activation of Aralar/MAS by small cytosolic calcium signals increases glycolysis and cytosolic pyruvate production, priming respiration as a feed-forward mechanism in response to workload. MCU and Aralar/MAS both contribute to the upregulation of oxidative phosphorylation, with Aralar/MAS playing a major role, particularly at small and submaximal workloads. These findings highlight the importance of calcium signaling and the Aralar/MAS pathway in cellular metabolism.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2023)

Review Biochemistry & Molecular Biology

Apoptotic cell death in disease-Current understanding of the NCCD 2023

Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, John M. Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Rami Aqeilan, Eli Arama, Eric H. Baehrecke, Siddharth Balachandran, Daniele Bano, Nickolai A. Barlev, Jiri Bartek, Nicolas G. Bazan, Christoph Becker, Francesca Bernassola, Mathieu J. M. Bertrand, Marco E. Bianchi, Mikhail V. Blagosklonny, J. Magarian Blander, Giovanni Blandino, Klas Blomgren, Christoph Borner, Carl D. Bortner, Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Broz, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona-Gutierrez, Francesco Cecconi, Francis K-M Chan, Guo-Qiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos-Ruiz, Peter E. Czabotar, Vincenzo D'Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus-Michael Debatin, Ralph J. Deberardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian D. Dynlacht, Wafik S. El-Deiry, John W. Elrod, Kurt Engeland, Gian Maria Fimia, Claudia Galassi, Carlo Ganini, Ana J. Garcia-Saez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Haecker, Gyorgy Hajnoczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jaeaettelae, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala-Devi Kanneganti, Michael Karin, Hamid Kashkar, Thomas Kaufmann, Gemma L. Kelly, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Ruth Kluck, Dmitri Krysko, Dagmar Kulms, Sharad Kumar, Sergio Lavandero, Inna N. Lavrik, John J. Lemasters, Gianmaria Liccardi, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos Lopez-Otin, Tom Luedde, Marion MacFarlane, Frank Madeo, Walter Malorni, Gwenola Manic, Roberto Mantovani, Saverio Marchi, Jean-Christophe Marine, Seamus J. Martin, Jean-Claude Martinou, Pier G. Mastroberardino, Jan Paul Medema, Patrick Mehlen, Pascal Meier, Gerry Melino, Sonia Melino, Edward A. Miao, Ute M. Moll, Cristina Munoz-Pinedo, Daniel J. Murphy, Maria Victoria Niklison-Chirou, Flavia Novelli, Gabriel Nunez, Andrew Oberst, Dimitry Ofengeim, Joseph T. Opferman, Moshe Oren, Michele Pagano, Theocharis Panaretakis, Manolis Pasparakis, Josef M. Penninger, Francesca Pentimalli, David M. Pereira, Shazib Pervaiz, Marcus E. Peter, Paolo Pinton, Giovanni Porta, Jochen H. M. Prehn, Hamsa Puthalakath, Gabriel A. Rabinovich, Krishnaraj Rajalingam, Kodi S. Ravichandran, Markus Rehm, Jean-Ehrland Ricci, Rosario Rizzuto, Nirmal Robinson, Cecilia M. P. Rodrigues, Barak Rotblat, Carla Rothlin, David C. Rubinsztein, Thomas Rudel, Alessandro Rufini, Kevin M. Ryan, Kristopher A. Sarosiek, Akira Sawa, Emre Sayan, Kate Schroder, Luca Scorrano, Federico Sesti, Feng Shao, Yufang Shi, Giuseppe S. Sica, John Silke, Hans-Uwe Simon, Antonella Sistigu, Anastasis Stephanou, Brent R. Stockwell, Flavie Strapazzon, Andreas Strasser, Liming Sun, Erwei Sun, Qiang Sun, Gyorgy Szabadkai, Stephen W. G. Tait, Daolin Tang, Nektarios Tavernarakis, Carol M. Troy, Boris Turk, Nicoletta Urbano, Peter Vandenabeele, Tom Vanden Berghe, Matthew G. Vander Heiden, Jacqueline L. Vanderluit, Alexei Verkhratsky, Andreas Villunger, Silvia von Karstedt, Anne K. Voss, Karen H. Vousden, Domagoj Vucic, Daniela Vuri, Erwin F. Wagner, Henning Walczak, David Wallach, Ruoning Wang, Ying Wang, Achim Weber, Will Wood, Takahiro Yamazaki, Huang-Tian Yang, Zahra Zakeri, Joanna E. Zawacka-Pankau, Lin Zhang, Haibing Zhang, Boris Zhivotovsky, Wenzhao Zhou, Mauro Piacentini, Guido Kroemer, Lorenzo Galluzzi

Summary: Apoptosis is a regulated cell death process involving caspase family proteases. Inhibiting or delaying apoptosis experimentally through pharmacological and genetic strategies has demonstrated its importance in embryonic development, tissue homeostasis, and the pathogenesis of various human disorders. Defects in apoptotic cell death machinery impair development and promote oncogenesis, while inappropriate activation of apoptosis contributes to cell loss and tissue damage in neurological, cardiovascular, renal, hepatic, infectious, neoplastic, and inflammatory conditions.

CELL DEATH AND DIFFERENTIATION (2023)

Editorial Material Biochemistry & Molecular Biology

The mitochondrial ATP synthase as an ATP consumer-a surprising therapeutic target

Gabriel E. Valdebenito, Anitta R. Chacko, Michael R. Duchen

Summary: The mitochondrial F1Fo-ATP synthase can both synthesize ATP and pump protons, with potential implications for diseases. In a recent study, Acin-Perez et al. identified (+)-epicatechin as a compound that selectively inhibits ATP hydrolysis without affecting ATP synthesis. They found that this compound has significant benefits for cell and tissue function in disease models, suggesting a novel therapeutic approach for mitochondrial disease.

EMBO JOURNAL (2023)

Article Genetics & Heredity

Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver

Luis Gonzalez-Moreno, Andrea Santamaria-Cano, Alberto Paradela, Maria Luz Martinez-Chantar, Miguel A. Martin, Mercedes Perez-Carreras, Alberto Garcia-Picazo, Jesus Vazquez, Enrique Calvo, Gloria Gonzalez-Aseguinolaza, Takeyori Saheki, Araceli del Arco, Jorgina Satrustegui, Laura Contreras

Summary: The deficiency of CITRIN, the liver mitochondrial aspartate-glutamate carrier (AGC), is the cause of four human clinical phenotypes. A potential therapy for this condition is the expression of aralar, the AGC present in brain, to replace citrin. To explore the significance of AGC replacement in human therapy, the relative levels of citrin and aralar in mouse and human liver were studied. The results support the benefit of increasing aralar expression to improve the redox balance capacity of human liver, as an effective therapy for CITRIN deficiency.

MOLECULAR GENETICS AND METABOLISM REPORTS (2023)

Article Cell Biology

IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype

Sonia Dominguez-Zorita, Ines Romero-Carraminana, Fulvio Santacatterina, Pau B. B. Esparza-Molto, Carolina Simo, Araceli del-Arco, Cristina Nunez de Arenas, Jorge Saiz, Coral Barbas, Jose M. Cuezva

Summary: ATPase Inhibitory Factor 1 (IF1) regulates mitochondrial ATP synthase activity and its expression is variable in differentiated human and mouse cells. Overexpression of IF1 protects intestinal cells against colon inflammation. A conditional IF1-knockout mouse model was developed to investigate the role of IF1 in mitochondrial function and tissue homeostasis. Results showed that lack of IF1 led to increased ATP synthase/hydrolase activities, mitochondrial dysfunction, and a pro-inflammatory phenotype in mice.

CELL DEATH & DISEASE (2023)

Article Cell Biology

Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects

Kim Han, Komudi Singh, Allison M. Meadows, Rahul Sharma, Shahin Hassanzadeh, Jing Wu, Haley Goss-Holmes, Rebecca D. Huffstutler, Heather L. Teague, Nehal N. Mehta, Julian L. Griffin, Rong Tian, Javier Traba, Michael N. Sack

Summary: NAD+ boosting can modulate adaptive immunity by reducing IFNg and IL-17 secretion, enhancing Th17 polarization, and reducing inflammation in psoriasis through activation of Nrf2 and increased antioxidant defenses.

CELL REPORTS MEDICINE (2023)

Article Physiology

Mitochondrial function and dysfunction in innate immunity

Aurea Oliva, Carolina Merono, Javier Traba

Summary: Mitochondria have a crucial role in the activation of the immune system, regulating cell metabolism and immune pathways. Dysregulation of mitochondria can lead to human diseases.

CURRENT OPINION IN PHYSIOLOGY (2022)

暂无数据